Clinomic

About the deal

Aachen, Germany, 8th April 2025 – Clinomic, an emerging leader in medical technology, revolutionizing intensive care medicine through its cutting-edge AI-driven solutions, today announced the closing of a €23 million financing round co-led by DeepTech & Climate Fonds (DTCF) and a private family office. The funds will be used to expand the company’s presence in global markets and further develop its AI-powered healthcare solutions.

Founded in 2019 by intensive care physicians from RWTH Aachen University Hospital, Clinomic developed Mona, an integrated platform designed to streamline intensive care workflows. Mona records, organizes, analyzes, and visualizes patient and operational data, providing healthcare professionals with real-time insights to enhance decision-making—transforming intensive care to meet both human and technological standards for patients and medical workers.